Full notification file
General informationNotification NumberB/NL/15/003Member State to which the notification was sentNetherlandsDate of acknowledgement from the Member State Competent Authority01/05/2014Title of the ProjectIntradermal vaccination with naked DNA, encoding the fusion protein of a carrier sequence sig-HELP-kdel and the shuffled version of the Human papilloma virus (HPV) E6 or E7 oncoprotein for the induction of E6 and E7 specific T cell immunity in patients with HPV induced (pre-)malignancies.Proposed period of release:01/09/2015 to 01/09/2025Name of the Institute(s) or Company(ies)Stichting Het Nederlands Kanker Instituut, Plesmanlaan 121
1066 CX Amsterdam
PO Box 90203
1006 BE Amsterdam;
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:Other: Purified plasmid DNA (pDNA) drug substance.Identity of the GMO:Not relevant. The plasmid DNAs does not have a taxonomic classification.Information relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | pUMVC3 | - | - | - | - | - |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known